Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review

NCT04609319 · clinicaltrials.gov ↗
COMPLETED
Status
307
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer